Company JW Lifescience Corporation

A234080

KR7234080000

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-07-03 pm EDT			5-day change	1st Jan Change
11,770 ^KRW	-0.17%		-0.93%	-8.55%

2023	JW Lifescience Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	JW Lifescience Corporation(KOSE:A234080) dropped from S&P Global BMI Index	CI

JW Life Science Co. Ltd. is a Korea-based company primarily engaged in manufacture and distribution of Intravenous (IV) fluid products and infusion solutions. The Company is engaged in manufacture of basic IV fluid including water, electrolytes and glucose; nutrient infusion solution including amino acids, lipids, proteins, vitamins and minerals; and special infusion solution, which is used in special cases. The Company is also engaged in manufacture of total parenteral nutrition (TPN) products and others.

Number of employees: 256

KRW in Million	2022	Weight	2023	Weight	Delta
Intravenous Fluids 100.0 %	188,931	100.0 %	206,860	100.0 %	+9.49%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	188,931	100.0 %	206,860	100.0 %	+9.49%

Managers	Title	Age	Since
Seong-Nam Cha CEO	Chief Executive Officer	67	-
Jung-Yeol Noh BRD	Director/Board Member	57	-
Cheol-Won Park AUD	Comptroller/Controller/Auditor	80	17-02-16

Members of the board	Title	Age	Since
Hyeon-Soon Lee BRD	Director/Board Member	73	-
Seong-Nam Cha CEO	Chief Executive Officer	67	-
Jung-Yeol Noh BRD	Director/Board Member	57	-
Byeong-Suk Lee BRD	Director/Board Member	68	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	15,834,554	8,563,266 ( 54.08 %)	350,000 ( 2.210 %)	54.08 %

Name	Equities	%	Valuation
JW HOLDINGS CORPORATION 42.98 %	6,806,168	42.98 %	59 M ₩
JW LIFESCIENCE CORPORATION 2.210 %	350,000	2.210 %	3 M ₩

Name	Equities	%	Valuation
JW LIFESCIENCE CORPORATION 2.21%	350,000	2.21%	3,051,171 $

JW Life Science Corp.

28 Hanjin 1-gil Songak-eup

31720, Dangjin-si

http://www.jw-lifescience.co.kr

address JW Lifescience Corporation(A234080)

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
JW LIFESCIENCE CORPORATION	-8.55%	132M
ELI LILLY AND COMPANY	+54.07%	809B
NOVO NORDISK A/S	+38.95%	621B
JOHNSON & JOHNSON	-7.05%	351B
MERCK & CO., INC.	+15.44%	319B
ABBVIE INC.	+5.72%	289B
ASTRAZENECA PLC	+14.21%	238B
ROCHE HOLDING AG	-0.45%	221B
NOVARTIS AG	+14.58%	218B
AMGEN INC.	+7.42%	166B

Other Pharmaceuticals